New Medications and Diagnostic Tests Approved by FDA

Dear Colleague,

In the past week, FDA released five press announcements for new drug approvals to treat conditions that disproportionately affect minorities, along with a new HIV test, and a proposed rule to make changes to the nutrition facts label. Click on the links below to find out more information.

1. FDA approves Praluent to treat certain patients with high cholesterol

2. FDA approves new treatment for chronic hepatitis C genotype 3 infections

3. FDA approves Technivie for treatment of chronic hepatitis C genotype 4

4. FDA approves diagnostic test to differentiate between types of HIV infection

5. FDA revises Nutrition Facts label rule to include a daily value for added sugars